Young, bright and committed to labtech

, becoming the new CEO of Swedish Labtech.

Multiple rotor options in refrigerated microcentrifuge

The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.

Life science in Stockholm

Sweden has the fourth-largest biotech market in Europe. More than half of its biotechnology enterprise, some 460 companies, is located in the Stockholm region.

Diagnostics to deal with new diseases

Maria Brytting at the Swedish Institute for Infectious Disease Control, SMI, will share her experiences from April 2009 when the new influenza A virus, H1N1, was first reported globally.

Age essential when testing drugs

Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established regulations stating that pharmaceuticals must be tested for children as well as for adults.

How to get the most out of the fair

Medicon Valley cluster in brief

The Medicon Valley covers the Öresund region (Skåne and Sjaelland).

Safe and economic dispensing of powders

Mettler Toledo is showcasing Quantos, an automated dispenser for laboratory use.

Hey Johannes Hedman...

... graduate of SKL and LTH, who has improved a method of forensic analysis

180 miljoner till nanoforskning

En stor satsning från det europeiska programmet Euro Nano Med ska finansiera två svenska nanoforskningsprojekt. Chalmers tekniska högskola, Linköpings universitet, Umeå universitet och Vironova får vara med och dela på pengarna.

The winner of the race

She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is focus according to Yvonne Mårtensson.

With their hands on the legal levers

It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.

El kan lindra Parkinson

Genom att stimulera nerver i ryggmärgen hoppas forskarna kunna minska medicindosen hos Parkinsonpatienter.

Stille ingår nytt globalt avtal

GE Healthcare ska distribuera och marknadsföra Stilles operationsbord i USA och på nya marknader.

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Faster sales but less profits for Probi

The probiotic company increases its turnover, and the net results are twice as large as last year.

Symphogen buys tumor blocking technology

The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten Drejer, CEO of Symphogen. Ph.D.

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and one is from the University of Uppsala.

Re-painting the big pig-ture

Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.

Athera signs production partnership

The companys novel cardiovascular product will be manufactured in Germany.

Test if you carry the fat virus

In a soon future there may be a quick and simple test that could show if you are infected with Ad-36, a human adenovirus that can make you over-weight.

Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

Grant for development projects in Gothenburg

Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.

Pfizer lays a chunky bid on Wyeth

The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at approximately $68 billion. The Boards of Directors of both companies have said yes to the deal that may lead to lay-offs of some 8,000 persons.